Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
Healthy Directions appeals NAD decision; FDA flags I. Shay for OTC ingredient violations, GMPs; Mushroom Wisdom mishandled AERs, says FDA; Health Breakthroughs warned for drug claims.